Michael C. Feld
Executive VP & Chief Revenue OfficerMr. Michael C. Feld was Executive VP, Chief Revenue Officer & President of Life Sciences Segmen of Becton, Dickinson and Company from October 15, 2025 to 2026. Mr. Feld was Executive VP & President of the Life Sciences Segment of Becton, Dickinson and Company from August 20, 2024. Mr. Michael C. Feld is Executive VP & Chief Revenue Officer of Becton, Dickinson and Company from 2026. Mr. Feld joined the Becton, Dickinson and Company on August 20, 2024. He joins BD from Veralto, a spin-off of Danaher, where he was president of Hach from September 2023 to August 2024, a global leader in water quality products. Prior to that, he held several senior roles at Danaher, including senior vice president and general manager of Cepheid Europe and served as president of several other Danaher businesses including Mammotome from January 2019 to September 2022, XOS and Dover Motion, all focused on strategic planning, superior quality, associate development and cultural progression.As president of the BD Life Sciences segment, which includes Biosciences, Diagnostics Solutions and Specimen Management, he will be responsible for an organization that is delivering innovative advancements from discovery to diagnosis. Under his leadership, BD Life Sciences will continue to focus on developing solutions around smart, connected, end-to-end workflows, specimen collection and diagnostics at new care settings, which will improve the diagnosis and treatment of chronic conditions. He was Senior Vice President and General Manager of Danaher Corporation from June 2022 to September 2023. He earned his Bachelor of Science degree from Tulane University and his Master of Business Administration from Northwestern University's Kellogg School of Management.
Positions
- Company NameBecton, Dickinson and CompanyStock CodeBDXPositionExecutive VP & Chief Revenue OfficerColleagues
- TEThomas E. PolenPresident, CEO & Chairman
- VRVitor RoqueExecutive VP & CFO
- EMElizabeth McCombsExecutive VP & CTO
- JMJoseph M. SmithSenior VP & Chief Scientific Officer
- CIChristopher Ian Montague JonesIndependent Director
- CMCatherine M. BurzikIndependent Director
- RARobert Andrew EckertLead Independent Director
- JWJeffrey W. HendersonIndependent Director
